Johnson Pharmacare Ltd
₹
- close price
About
Incorporated in 1994, Johnson Pharmacare Ltd. (formerly Robinson Worldwide Trade Ltd) is involved in trading business and provides business services.
Key Points
- Market Cap ₹ Cr.
- Current Price ₹
- High / Low ₹ /
- Stock P/E
- Book Value ₹
- Dividend Yield %
- ROCE %
- ROE %
- Face Value ₹
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Dividend Payout % |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Figures in Rs. Crores
| Equity Capital |
| Reserves |
| Total Liabilities |
| CWIP |
| Investments |
| Total Assets |
Cash Flows
Figures in Rs. Crores
| Net Cash Flow |
| Free Cash Flow |
| CFO/OP |
Ratios
Figures in Rs. Crores
| Debtor Days |
| Inventory Days |
| Days Payable |
| Cash Conversion Cycle |
| Working Capital Days |
| ROCE % |
Insights
In beta| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| Investments held (Non-Current & Current) INR Lakhs ・Standalone data |
|
||||||
| Loans Given to Others INR Lakhs ・Standalone data |
|||||||
| Revenue from Operations (Operational Activity Status) INR ・Standalone data |
|||||||
Requires Premium
Requires Premium
Extracted by Screener AI
Documents
Announcements
-
Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
9 May - Company confirms it is not a Large Corporate for year ended March 31, 2026.
-
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
30 Apr - Johnson Pharmacare confirms it is not a Large Corporate for FY 2025-26 under SEBI debt rules.
-
Announcement under Regulation 30 (LODR)-Resignation of Director
17 Apr - Board approved resignations of Rajender Parsad and Umesh Kumar effective 17 April 2026.
-
Announcement under Regulation 30 (LODR)-Change in Management
17 Apr - On 17 Apr 2026, board appointed Nand Kishore Ray and Dheeraj Kumar as additional directors.
-
Board Meeting Outcome for Outcome Of Meeting Of Board Pursuant To Regulation 30 Of The SEBI
(LODR) Regulations, 2015.
17 Apr - Board appointed two additional directors and approved two director resignations effective 17 April 2026.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Services Offered:[1]
Company used to provide commercial services like purchase and sales of various good and services. Company also buys, trades, and sells shares and investments.